Expanding healthcare systems in countries such as China and India, along with improved access to advanced therapies, are strengthening demand for effective glucose-lowering and weight-management treatments
This has as much to do with ease of cultivation and preservation for sale as with their specific effects
Recent studies have demonstrated a direct hormonal link between bone remodeling, food intake, and glucose metabolism, and the involvement of MOTS-c in bone metabolism (Lee et al., 2015
Standard Copper Peptides GHK-Cu's defined structure, extensive research literature, and specific CAS number make it the preferred copper peptide for reproducible research
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK as Mounjaro for the treatment of type 2 diabetes mellitus and as Zepbound for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association [published online ahead of print March 8, 2025]